blood test

Metabolomic Diagnostics Completes €0.75 Million Investment Round

Metabolomic Diagnostics Logo

We are pleased to announce that IMPROvED Partner Metabolomic Diagnostics has secured €750,000 in venture funding through a syndicate of investors including SOSventures Ireland Fund, AIB Seed Capital Fund and Enterprise Ireland.   
 
Metabolomic Diagnostic’s innovative solution has the potential to revolutionise pre-natal care with its breakthrough blood test “PrePsia” for early detection of women at high risk of developing pre-eclampsia during their pregnancy.
 

Subscribe to RSS - blood test